LONDON and BOSTON — Synthace, the leading digital experiment platform for life science R&D, today announced the appointment of Willem Baralt as its new Chairman of the Board. Mr. Baralt joined the company in February 2024 during a period of accelerating growth, as Synthace expands its offerings. “I am thrilled to welcome Willem aboard,” said Guy Levy-Yurista, PhD, CEO of Synthace. “His addition marks […]
HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Roop K. Lakkaraju will join the company as its new Executive Vice President and Chief Financial Officer, effective April 15, 2024. Mr. Lakkaraju joins Bio-Rad from Benchmark Electronics, a multi-national leader […]
Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outlook FREMONT, Calif. — Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that William (Bill) McCombe has been appointed chief financial officer of the company effective immediately. McCombe brings experience as a public company CFO at both large scale, and […]
WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax. This appointment expands the size of Repligen’s board from eight to nine members. Ms. Pax brings to Repligen over 25 years of experience leading the development and execution of growth strategies for […]
CAMBRIDGE, Mass. – Data-driven laboratory and manufacturing operational connectivity pioneer Elemental Machines announced the addition of Rob Estrella as its new SVP of Global Sales. Estrella joined Elemental Machines to support their continued and deep commitment to serving the life sciences market and growth of enterprise-level Internet of Things (IoT) technology across laboratory and manufacturing spaces. Elemental Machines is […]
SAN JOSE, Calif. — Nodexus Inc., an emerging leader in automated benchtop single-cell characterization and microfluidic isolation technologies, today announced that William (Bill) Rhodes has been named Executive Chairman of the company’s Board of Directors. Rhodes has served on the Nodexus Board as an Independent Director since 2021 and was previously an Advisor to the […]
Abcam today announced the appointment of Markus Lusser as President. A seasoned Danaher executive, Markus joins Abcam at a pivotal moment as the company transitions into the Danaher Life Sciences portfolio. His extensive commercial and digital experience across the life sciences and medical device industries will help build on Abcam’s momentum to deliver innovative solutions […]
Executive brings more than 25 years of experience in life sciences SAN JOSE, Calif. – Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), today announced Mary Duseau’s appointment as its new president, succeeding interim president, Greg Milosevich. “Mary brings more than 25 […]
Key appointment to lead global commercial launch of eProtein Discovery platform Cambridge, UK: Nuclera, the biotechnology company enabling rapid protein expression and purification screening through its benchtop protein platform, today announced the appointment of Joseph Bertelsen as Chief Commercial Officer (CCO). With over 20 years’ commercial leadership experience in the life science tools and drug development […]
Following discussions with the board, the company’s founders Erik Gatenholm and Hector Martinez are leaving BICO after eight years. “I want to thank Erik and Hector for their efforts. Without them, the company would not have existed, let alone contributed to the change in the industry,” says Rolf Classon, Chairman of the Board. “I wish […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
